scholarly journals Randomized clinical trial comparing the efficacy and safety of treatment with the once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor omarigliptin or the once-daily DPP-4 inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled on m

2017 ◽  
Vol 19 (3) ◽  
pp. 394-400 ◽  
Author(s):  
Ronald Goldenberg ◽  
Ira Gantz ◽  
Paula J. Andryuk ◽  
Edward A. O'Neill ◽  
Keith D. Kaufman ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Dipeptidyl Peptidase ◽  
Efficacy And Safety ◽  
Once Daily ◽  
Dipeptidyl Peptidase 4

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor PF-734200 added to metformin in Type 2 diabetes

2011 ◽  
Vol 28 (4) ◽  
pp. 464-469 ◽  
Author(s):  
J. Rosenstock ◽  
A. J. Lewin ◽  
P. Norwood ◽  
V. Somayaji ◽  
T. T. Nguyen ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Dipeptidyl Peptidase ◽  
Efficacy And Safety ◽  
Dipeptidyl Peptidase 4 ◽  
Dipeptidyl Peptidase 4 Inhibitor
Sign in / Sign up

Export Citation Format

Share Document